1-7 of 7
William Van der Touw
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Lintuzumab-Ac225, a CD33-Directed Antibody Radiotherapy, Targets AML in a Mutation Agnostic Manner

Amanda Chin, Rubin Jiao, Kevin J.H. Allen, Jason Li, Mary Chen, Madhuri Vusirikala, Le-Cun Xu, Patrik Brodin, Monideepa Roy, Mackenzie Malo, William Van der Touw, Ekaterina Dadachova, Denis Beckford-Vera, Helen Kotanides
Journal: Blood
Blood (2023) 142 (Supplement 1): 5750.
https://doi.org/10.1182/blood-2023-187498
Published: 2023
Journal Articles

Development of CD19 CAR Engineered Human Placental CD34 + -Derived Natural Killer Cells (CAR19-CYNK) As an Allogeneic Cancer Immunotherapy

Marina Gergues, Irene Raitman, Joseph Gleason, Valentina Rousseva, Shuyang He, William Van Der Touw, Qian Ye, Lin Kang, Yanliang Zhang, Chin-I Pai, Wenzhong Guo, Henry Ji, Robert Hariri, Xiaokui Zhang
Journal: Blood
Blood (2021) 138 (Supplement 1): 2779.
https://doi.org/10.1182/blood-2021-150593
Published: 2021
Journal Articles

Human Placental CD34 + -Derived Natural Killer Cells with High Affinity and Cleavage Resistant CD16 (CYNK-101) in Combination with Daratumumab for Immunotherapy Against CD38 Expressing Hematological Malignancies

Irene Raitman, Joseph Gleason, Salvatore Rotondo, Shuyang He, Valentina Rousseva, Xuan Guo, Hemlata Rana, William van der Touw, Qian Ye, Lin Kang, Robert Hariri, Xiaokui Zhang
Journal: Blood
Blood (2021) 138 (Supplement 1): 2773.
https://doi.org/10.1182/blood-2021-148869
Published: 2021
Journal Articles

Human Placental CD34 + -Derived Natural Killer Cells with High Affinity and Cleavage Resistant CD16 (CYNK-101) for ADCC Mediated Cancer Immunotherapy

Lin Kang, Irene Raitman, PhD, Salvatore Rotondo, MS, Joseph Gleason, MS, Shuyang He, PhD, Srinivas Somanchi, PhD, Valentina Rousseva, MS, Xuan Guo, PhD, Hemlata Rana, MS, Andrea DiFiglia, BS, Qian Ye, PhD, Tanel Mahlakõiv, PhD, William Van Der Touw, Robert Hariri, MD PhD, Xiaokui Zhang, PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 1.
https://doi.org/10.1182/blood-2020-140536
Published: 2020
Journal Articles

Human Placental Hematopoietic Stem Cell Derived Natural Killer Cells (CYNK-001) Mediate Protection Against Influenza A Viral Infection

Shuyang He, PhD, Tanel Mahlakõiv, PhD, Joseph Gleason, MS, William Van Der Touw, Lin Kang, Robert Hariri, MD PhD, Xiaokui Zhang, PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 2–3.
https://doi.org/10.1182/blood-2020-139049
Published: 2020
Journal Articles

Results of a Phase I Study of Pnk-007, Allogeneic, Off the Shelf NK Cell, Post Autologous Transplant in Multiple Myeloma (NCT02955550)

Sarah A. Holstein, MD PhD, Sarah Cooley, MD, Parameswaran Hari, MBBS, MD, Sundar Jagannath, MD, Catherine R Balint, BSc, William Van Der Touw, Michele L. Donato, MD, Philip L. McCarthy, MD, Paul K. Wallace, MS, PhD, Xiaokui Zhang, PhD, Robert Hariri, MD PhD, Mohamad A. Hussein, MDMBBS, Ravi Vij, MBBS
Journal: Blood
Blood (2019) 134 (Supplement_1): 4451.
https://doi.org/10.1182/blood-2019-128467
Published: 2019
Journal Articles

Immune Monitoring of CD34+ Placental Cell Derived Natural Killer Cell Therapy (PNK-007) in Phase I Study of Multiple Myeloma

William Van Der Touw, Lin Kang, PhD, Joseph Dennis Tario, PhD, Bhavani Stout, Vanessa Voskinarian-Berse, Valentina Rousseva, Paul K. Wallace, MS, PhD, Robert Hariri, MD PhD, Xiaokui Zhang, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4457.
https://doi.org/10.1182/blood-2019-124509
Published: 2019